Connect with us

Technology

Power Wins DPHARM Idol Disrupt 2024 by Connecting Patients and Sites to Clinical Trials with a Simplified Platform

Published

on

The Conference Forum is pleased to announce that Power is the winner of DPHARM Idol Disrupt at the 14th annual DPHARM: Disruptive Innovations to Advance Clinical Research 2024 event.

PHILADELPHIA, Sept. 18, 2024 /PRNewswire-PRWeb/ — The Conference Forum is pleased to announce that Power is the winner of DPHARM Idol Disrupt at the 14th annual DPHARM: Disruptive Innovations to Advance Clinical Research 2024 event.

“AI-driven curation of patient-friendly lay language is a game-changer. Power has unlocked access to clinical trials in a low-overhead, AI-forward way, and is helping patients not only find trials, but learn more about them and connect directly to a clinical research site,” Nicole Sheetz, Gilead.

Power, represented by Brandon Li, Co-Founder, is building patient-friendly access to clinical trials, and is simplifying recruitment with a novel AI approach that delivers qualified referrals that match protocol criteria and supports the entire process through to enrollment.

“Roughly 86% of all clinical trials are delayed due to an inability to recruit enough patients. By making it dead simple to discover and evaluate novel therapies, we’re hoping to offer patients a source of hope while reducing the time it takes for new breakthrough drugs to reach approval,” said Mr Li.

In front of 12 judges representing R&D executives, patient advocates, and life science investors, Power had six minutes to present how their platform helped patients navigate clinical trial options, scanned patient-uploaded medical documents for inclusion/exclusion criteria to match patients to potential trials, and let patients browse nearby sites. Mr Li also told the DPHARM audience that physicians and care providers had begun using the platform as well.

“AI-driven curation of patient-friendly lay language is a game-changer. Power has unlocked access to clinical trials in a low-overhead, AI-forward way, and is helping patients not only find trials, but learn more about them and connect directly to a clinical research site,” said Nicole Sheetz, PharmD, Senior Director, Design & Innovation, Global Development, Gilead.

“Patients are always looking for information, and it’s hard to make a decision in a pressurized environment. Power makes it clean, simple and user-friendly. When patients understand and retain information, especially from underrepresented communities, they are more likely to engage and exercise their options,” said Karen Peterson, Founder and Chief Patient Advocate, Karen’s Club.

Power had strong competition from the other DPHARM Idol Disrupt finalist contenders, which included:

Beaconcure, represented by Ilan Carmeli, COO and Co-Founder, and Sean Wall, SVP, CommercialThoughtSphere, represented by Avi Kulkarni, PhD, CEOInspire, represented by Brett Kleger, CEOProofPilot, represented by Chris Venezia, CEOInSilicoTrials, represented by Mario Torchia, Chief Operating Officer, and MaryAnne Rizk, Advisor

The DPHARM Idol Disrupt 2024 judges were:

Mohammed Ali, R&D Head of Business Performance & Analytics, CMO Office, AstellasMary Brantner, Senior Director, Clinical Program Optimization and Innovation, Insmed IncorporatedEsther Dyson, Founder, WellvilleBill Illis, Head, Technology and Collaboration, NovartisHassan Kadhim, Business Engagement Lead for Clinical Operations and Development, Vertex PharmaceuticalsKaren Peterson, Founder and Chief Patient Advocate, Karen’s ClubDoug Schantz, SVP, Clinical Operations, Asklepios BioPharmaceutical, Inc.Nicole Sheetz, PharmD, Senior Director, Design & Innovation, Global Development, GileadLauren Sunshine, Director, Product Management, Digital Health, BMSMark Travers, PhD, MBA, VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.Donna Usiskin, Chief Strategy Officer, New Enterprise VenturesHenry Wei, MD, Head of Development Innovation, Regeneron Pharmaceuticals Inc

The DPHARM Idol Disrupt 2024 moderator was:

Sheryl Jacobs, VP, Global Development Operations, Amgen

For more information, please contact service@tcfllc.org or visit theconferenceforum.org.

About DPHARM:
DPHARM® offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders report on the latest innovations to Advance clinical trials. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program.

About The Conference Forum:
The Conference Forum is a life science industry research firm that brings key people together to share and exchange ideas and information on how to get therapeutics to patients faster. We continue to examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common, patient-centered goals. Each of our key research areas – Clinical Trial Innovation, Patients as Partners, R&D Leadership, Immuno-Oncology, Drug Delivery and Clinical Research as a Care Option – has a dedicated conference, quarterly newsletter and podcasts.

Media Contact

Danny McCarthy, DPHARM, 646-350-2580, service@tcfllc.org, https://dpharmconference.com/

View original content:https://www.prweb.com/releases/power-wins-dpharm-idol-disrupt-2024-by-connecting-patients-and-sites-to-clinical-trials-with-a-simplified-platform-302251881.html

SOURCE DPHARM

Continue Reading

Technology

NatGold Digital Announces Immediate Delisting of NATG from MEXC Following U.S. Treasury Action

Published

on

By

CORAL GABLES, Fla., Nov. 7, 2026 /PRNewswire/ — NatGold Digital Ltd. (“NatGold” or the “Company”) today announced that it has requested the delisting of the NatGold Token (NATG) from MEXC, a global cryptocurrency exchange where NATG is currently listed, with immediate effect.

The decision follows the U.S. Department of the Treasury’s announcement of an order issued by its Financial Crimes Enforcement Network (FinCEN) under the Combating Russian Money Laundering Act, prohibiting U.S. financial institutions from processing funds transfers involving MEXC Global.

NatGold is a U.S. company whose wholly owned subsidiary, NatGold Integrity Vault LLC, is registered with FinCEN as a money services business. The Company is acting ahead of the order’s effective date.

“As a U.S. company operating through a FinCEN-registered money services business, we are acting immediately in response to Treasury’s decision,” said Mark Radke, Executive Chairman of NatGold Digital. “Trust is a cornerstone of NatGold’s operating structure, and responding promptly to this regulatory action reflects that commitment.”

NatGold is in advanced discussions with multiple regulatory-compliant exchanges and venues  serving global markets, including the United States, and intends to replace MEXC as soon as possible. Once new listings are confirmed, NATG token holders will be advised of the arrangements and encouraged to register accounts and link their wallets, as applicable, to continue trading.

About NatGold Digital Ltd.

NatGold Digital Ltd. is the global leader in digital gold mining and the architect and operator of a patent-pending, non-extractive platform designed to unlock the intrinsic value of technically verified in-ground gold resources that remain securely stored in Mother Nature’s Vault. NatGold Tokens are structured to represent standardized unit interests in NatGold Certified Resources, disclosed under internationally recognized geological Technical Reports — without physical extraction, processing, or movement of gold. The result is a superior fiat money alternative designed to help lead a global monetary reformation.

For additional background, please visit NatGold.com or our official YouTube channel for videos and information about our digital mining ecosystem: youtube.com/@NatGold_Digital.

Contact

Media@NatGold.com
InvestorServices@NatGold.com
+1 (646) 825-3038

The information in the above release has been prepared by NatGold Digital Ltd. (“NatGold”) using its best efforts to realistically and factually present the information contained herein. However, subjective opinion, reliance on factors outside NatGold’s control, and external information sources unavoidably mean that NatGold cannot warrant the information to be exhaustive, complete, or sufficient. The information provided herein is intended solely for general informational purposes and does not constitute an offer or solicitation for the purchase or sale of any shares or securities of NatGold or for the purchase or sale of any NatGold Tokens. NatGold Tokens are not intended to be “securities” in any jurisdiction, and NatGold makes no claim or representation related to the value of NatGold or NatGold Tokens. Potential investors should seek advice from a qualified financial dealer before investing in NatGold. There are substantial risks associated with investing in development-stage digital assets and technology companies.

View original content to download multimedia:https://www.prnewswire.com/news-releases/natgold-digital-announces-immediate-delisting-of-natg-from-mexc-following-us-treasury-action-302932601.html

SOURCE NatGold Digital Ltd.

Continue Reading

Technology

What to Look for in an Online GLP-1 Provider: Meant Outlines Five Questions Worth Asking Before Signing Up

Published

on

By

MANASSAS, Va., Nov. 7, 2026 /PRNewswire/ — As more telehealth companies offer GLP-1 care, the options can look alike from the outside, and telling them apart takes more than a glance at a landing page. Meant is sharing five questions consumers can ask when choosing an online GLP-1 provider, along with how it approaches each one.

Five Questions Worth Asking

Who makes the clinical decisions? A trustworthy provider should be clear about which licensed clinicians review each person’s information. At Meant, those decisions are made by licensed providers through its clinical partner, OpenLoop Health.Is there a real evaluation first? Look for a health-history review before anything is prescribed, and for plain language that a prescription is never guaranteed. Meant’s online assessment covers health history, current medications, and goals.Can the company’s credentials be checked? Independent certifications are one signal consumers can verify for themselves. Meant displays the seal for its LegitScript certification on its website.Is it clear who fills prescriptions? Providers should be open about the pharmacies they work with and whether those pharmacies are licensed in the United States.Is ongoing support spelled out, limits included? Good providers explain what follow-up looks like and who handles which questions. Meant pairs care with an optional Care Coach, and medical questions go to the care team.

A certification is a transparency signal, not a government approval or a promise about results, and no checklist replaces a conversation with a licensed clinician. Meant does not diagnose or prescribe, and treatment is not guaranteed for every applicant.

Take a Closer Look

Consumers who want to see how the assessment, clinical oversight, and coaching fit together can visit Meant‘s website and compare the details against the questions above.

About Meant

Meant is a health and wellness technology company focused on personalized GLP-1 weight-care support delivered through telehealth. The platform combines an online clinical assessment, licensed oversight through OpenLoop Health, Care Coach support, and supplemental wellness resources. Meant does not itself diagnose or prescribe; clinical decisions are made by its clinical partners. Learn more at meant.health.

Meant Health, Inc.
support@meant.health
1-512-879-9187
10199 Dean Drive, Manassas, VA 20110, USA

View original content:https://www.prnewswire.com/news-releases/what-to-look-for-in-an-online-glp-1-provider-meant-outlines-five-questions-worth-asking-before-signing-up-302927805.html

SOURCE Meant

Continue Reading

Technology

Capturing the Beauty of Anhui through Images–2026 Anhui Photography Season Concludes

Published

on

By

HUANGSHAN, China, Nov. 7, 2026 /PRNewswire/ — A news report from Crionline.

Spanning summer and autumn across three successive photography tours, the “Picturesque Anhui • Imaging Anhui” 2026 Anhui Photography Season officially wrapped up on November 4. Co-hosted by the Fédération Internationale de l’Art Photographique (FIAP), the Anhui Provincial Department of Culture and Tourism, and the Foreign Affairs Office of Anhui Provincial People’s Government, the event drew 116 photographers from 38 countries and regions. They visited 46 distinctive cultural and tourism attractions across five cities: Hefei, Chizhou, Anqing, Huangshan and Xuancheng. Through their lenses, they presented Anhui’s landscapes, cultural heritage and vibrant everyday life to the world.

Looking back on the three sessions: The first session kicked off in Hefei. Photographers documented the city’s innovation-driven urban landscape as well as the picturesque scenery and intangible cultural heritage of Chizhou’s ancient villages. The second session took them deep into Huangshan and Anqing. They explored time-honored Huizhou villages, magnificent mountains and Huangmei Opera culture, immersing themselves in Huizhou traditions and the cultural charm of the Yangtze River region in western Anhui. The concluding third session was held in Huangshan and Xuancheng, focusing on brilliant autumn hues, Huizhou‑style ancient architecture, and the traditional craftsmanship behind the Four Treasures of the Study.

From lush summer greens to rich autumn colours, the photographers produced more than 11,000 high‑resolution photographs. Reflecting the unique perspectives of international participants, these images will be disseminated globally in diverse forms. They will help tell compelling stories of Anhui’s cultural tourism and further boost the province’s international profile.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/capturing-the-beauty-of-anhui-through-images2026-anhui-photography-season-concludes-302932583.html

SOURCE Crionline

Continue Reading

Trending